Managed Entry in Europe - Challenges and Opportunities
Date and time
Location
Online event
Refund policy
Contact the organiser to request a refund.
Eventbrite's fee is nonrefundable.
Do you know what challenges and opportunities managed entry will present in the future for you and for your pharma partners?
About this event
SPECIAL EVENT
Interest in managed entry has grown in recent years in response to the increase in the number of high-priced drugs reaching the market, often with immature evidence bases at launch. However, managed entry agreements can entail a significant administrative burden and are not suitable for all new drugs.
Join us for this special one-off event where Neil Grubert will take us through how pharmaceutical companies are preparing for the challenges and opportunities that managed entry presents for new medicines entering the European market and what these will mean for your business.
All attendees will learn:
- How European countries differ in their policies on managed entry and how attitudes are changing
- What the three main objectives of managed entry are and how are they served by different types of agreements
- How Italy has been a long-standing pioneer of managed entry
- What action has Spain taken to boost managed entry
- Why outcomes-based agreements have been slow to evolve in France and Germany
- What can be learned from the UK experience
- What impact managed entry may have on access in the years ahead
